Uranium stocks surge following announcement of $US100m deal

Sky News Business Editor Ross Greenwood says the uranium sector has been on a tear this week – thanks to the launch of a new uranium investment fund.
The fund called Sprott has pledged to spend $US100 million on uranium.
The share price of uranium companies reacted by gains of up to 11 per cent in some cases.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Sky News AU

5 hours ago

• Sky News AU

Qatar Airways partners with Virgin Australia, directly competes with Qantas

Sky News host Ross Greenwood discusses Qatar Airways' 25 per cent ownership in Virgin Australia, claiming Qantas will now have more international competition after the Australian Government 'knocked back' Qatar Airways in the past. 'Qatar, you know, sort of, is obviously, been this week named as the best airline in the world,' Mr Greenwood told Sky News host Steve Price. 'The key for that is really that they own now 25 per cent of Virgin – Virgin is about to list on the Australian Stock Exchange, or re-list after it had previously gone broke. 'Given the fact that in the past, Qatar has really tried to get more flights into Australia, been knocked back by the Australian Government, and whether this tie-up now really does mean it's going to create more international competition for Qantas.'

News.com.au

7 hours ago

• News.com.au

Israel-Iran War: Blocking the Strait of Hormuz is ‘worst-case scenario' for oil prices

ANZ Senior Commodity Strategist Daniel Hynes says the worst-case scenario in the Israel-Iran conflict is the blocking of the Strait of Hormuz and how this will directly impact oil prices. 'The US is the wildcard here, and while we don't know how Iran would retaliate, certainly there are scenarios, as I said, where they could try and hurt the US by pushing oil prices higher,' Mr Hynes told Sky News Business Reporter Edward Boyd. 'Worst case scenario, that the Strait of Hormuz is completely blocked, then, there's no manner of supply that would be able to replace that quickly.'

Sydney Morning Herald

8 hours ago

• Sydney Morning Herald

ASX Runners of the Week: Amplia, archTIS and Vanadium Resources

If you were looking for correlation between the seemingly continuous breakouts of military hostilities between nuclear-armed nations and the market - good luck. The ASX continued at near all-time highs this week, pulling back a fraction by Friday, as conflict between Iran and Israel continued to rise. The oil price surged a further 10 per cent this week as Israel turned its focus from Iran's nuclear facilities to targeting its oil and gas infrastructure. Uranium stocks were the week's main winners. Surprisingly, they were not fuelled directly by global drivers, but rather by investment heavyweight Sprott's physical uranium trust purchase of $200 million worth of uranium oxide, which was announced on Monday. The result for uranium stocks on the index was deafening. Uranium miners Boss Energy, Paladin Energy and Deep Yellow were among the most heavily shorted on the ASX, making up three of the top 10 shorted companies. A sharp increase in uranium caused a two-fold effect of en masse buying and short seller panic to close out positions, with the big three uranium stocks all surging up 20 per cent on the day. In a rare shake-up, no Australian-based resource companies feature on this week's Bulls N' Bears' ASX Runners list. Instead, the chocolates went to a groundbreaking Aussie biotech story, which could be on to the makings of one of the biggest breakthroughs in oncology treatment in years. Up 339% (5.7c – 25c) This week's Bulls N' Bears ASX Runner of the Week is biotech trailblazer Amplia Therapeutics, which sent the market into an absolute tailspin thanks to a jaw-dropping set of results from a clinical trial for incredibly nasty pancreatic cancer.